SHP Wealth Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

SHP Wealth Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-125	Closed	-$31	–	2064
2026 Q1	$31	Hold	125	–	–	﹤0.01%	1801
2025 Q4	$52	Buy	+125	New	+$66	﹤0.01%	1524

Other funds holding SGMO

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

SHP Wealth Management's SGMO Position: Q2 2026 in Review

SHP Wealth Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 125 shares — an estimated $31 sold.

SHP Wealth Management first reported a position in SGMO in Q4 2025 and held it in 2 quarters. The position peaked at $52 in Q4 2025. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

SHP Wealth Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
SHP Wealth Management sold 125 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $31.
SHP Wealth Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2025 and held it in 2 quarters.
SHP Wealth Management's SANGAMO THERAPEUTICS INC position peaked at $52 in Q4 2025.
6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.